Skip to main content
Back to blog

Reimagining Cancer Care in England: What the National Cancer Plan Aims to Achieve

NHS Policy & Updates · Tamsin Rudolph

The National Cancer Plan for England outlines a long-term vision to transform cancer care, moving away from short-term fixes toward coordinated system-wide improvements. The strategy emphasizes better survival rates, earlier diagnosis, personalized care, research advancement, and inequality reduction.

Global Leader in Cancer Survival

A primary goal targets 75% of cancer patients to be cancer-free or living well five years post-diagnosis by 2035, potentially saving approximately 320,000 additional lives. This represents a shift from incremental improvement towards genuine transformation addressing underlying causes rather than managing systemic pressures.

Faster, Smarter Diagnosis and Treatment

The plan commits to delivering 9.5 million additional diagnostic tests by 2029 with £2.3 billion investment, rolling out national lung cancer screening by 2030, and expanding artificial intelligence and robotics in imaging and pathology. Early diagnosis remains one of the strongest predictors of cancer survival.

Personalised, Patient-Centred Care

Key commitments include individualized cancer care plans for every patient, expanded digital tools through the NHS App for appointment and screening management, and strengthened community-based and neighbourhood support systems. The approach recognizes the wider physical, emotional and social impact of a cancer diagnosis.

Research, Trials and Innovation

The strategy aims to strengthen England's research leadership by increasing clinical trial participation, including for underrepresented populations, and leveraging genomics, diagnostics, and data analytics.

Tackling Inequality and Prevention

Priorities address socioeconomic disparities in cancer outcomes through improved diagnostic access in deprived communities and strengthened prevention initiatives targeting smoking, obesity, and other risk factors.

Conclusion

This is the most comprehensive cancer strategy in a generation, requiring sustained delivery over ten years to achieve world-class, effective, humane, and resilient cancer care.